Arkolith/Insider Trading/CLDI/Form 4

Jackson Andrew C.

Chief Financial OfficerCalidi Biotherapeutics, Inc. (CLDI) · full profile →Form 4 · filed Aug 25, 2025
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 21, 2025Buy(P)3K$2.00$5K3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 21, 2025Buy(P)3K——3K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641172-25-025445) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML